Cellular uptake and in vivo distribution of polyhistidine peptides

被引:56
作者
Iwasaki, Takashi [1 ]
Tokuda, Yoshihisa [1 ]
Kotake, Ayaka [1 ]
Okada, Hiroyuki [3 ]
Takeda, Shuji [3 ]
Kawano, Tsuyoshi [1 ]
Nakayama, Yuji [2 ]
机构
[1] Tottori Univ, Grad Sch Agr Sci, Dept Bioresources Sci, Tottori 6808553, Japan
[2] Tottori Univ, Res Ctr Biosci & Technol, Div Funct Genom, Yonago, Tottori 6838503, Japan
[3] Asubio Pharma Co Ltd, Fac Exploratory Technol, Kobe, Hyogo 6500047, Japan
关键词
Cell-penetrating peptide (CPP); Histidine; Endocytosis; Macropinocytosis; Human fibrosarcoma; ARGININE-RICH PEPTIDES; PENETRATING PEPTIDES; PLASMA-MEMBRANE; PH; INTERNALIZATION; TUMORS; CELLS; SERUM; ACID;
D O I
10.1016/j.jconrel.2015.05.268
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Cell-penetrating peptides (CPPs) are arginine/lysine-rich sequences, and they are effectively internalized into cells. In this process, positive charge is crucial. In the present study, we found polyhistidine peptides (PHPs), as the novel CPP, which are efficiently internalized into cells in a positive charge-independentmanner. Interestingly, cellular uptake of the PHPs increased as the chain length increased, reaching a maximum uptake at H16 (HHHHHHHHHHHHHHHH-NH2). This H16 peptide showed up to 14.6-fold higher cell-penetrating capacity against HT1080 human fibrosarcoma cells relative to a major CPP, the octa-arginine (RRRRRRRR-NH2) peptide. Cellular uptake of the H16 peptide is mainly due to macropinocytosis and most of the H16 peptide localizes in the lysosome and Golgi apparatus. However, a cytoplasmic pro-apoptotic domain (KLAKLAKKLAKLAK-NH2) conjugated to the H16 peptide showed cytotoxic effects. This indicates that a proportion of the H16 peptide escapes from the macropinosome to the cytoplasm. In a protein transduction study, green fluorescence protein fused to the H16 peptide (GFP-H16) was purified by Ni-NTA chromatography, detected using an anti-His-tag antibody and internalized into cells. This serial process reveals thatH16 functions as a His-tag and protein transduction domain. Furthermore, in vivo distribution analysis showed that the H16 peptide accumulates immediately in tumor tissue and is retained up to 132 h following injection into the tumor (HT1080 human fibrosarcoma)-bearing mice. This is the first observation of a His-polymer being internalize into cells efficiently. The findings suggest that PHPs are novel CPPs. In particular, the H16 peptide represents a promising drug delivery carrier candidate in medical and biotechnological fields. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:115 / 124
页数:10
相关论文
共 33 条
[21]   THE EFFECT OF BLOOD-FLOW MODIFICATION ON INTRA- AND EXTRACELLULAR PH MEASURED BY P-31 MAGNETIC-RESONANCE SPECTROSCOPY IN MURINE TUMORS [J].
MCCOY, CL ;
PARKINS, CS ;
CHAPLIN, DJ ;
GRIFFITHS, JR ;
RODRIGUES, LM ;
STUBBS, M .
BRITISH JOURNAL OF CANCER, 1995, 72 (04) :905-911
[22]   Arginine-rich cell penetrating peptides: from endosomal uptake to nuclear delivery [J].
Melikov, K ;
Chernomordik, L .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2005, 62 (23) :2739-2749
[23]   STUDIES WITH GLYCOLYSIS-DEFICIENT CELLS SUGGEST THAT PRODUCTION OF LACTIC-ACID IS NOT THE ONLY CAUSE OF TUMOR ACIDITY [J].
NEWELL, K ;
FRANCHI, A ;
POUYSSEGUR, J ;
TANNOCK, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (03) :1127-1131
[24]  
Pan James G, 2007, Sci STKE, V2007, ppe14
[25]   Cell-surface proteoglycans as molecular portals for cationic peptide and polymer entry into cells [J].
Poon, G. M. K. ;
Gariepy, J. .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 :788-793
[26]   Translocation of molecules into cells by pH-dependent insertion of a transmembrane helix [J].
Reshetnyak, YK ;
Andreev, OA ;
Lehnert, U ;
Engelman, DM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (17) :6460-6465
[27]   Cell-penetrating peptides - A reevaluation of the mechanism of cellular uptake [J].
Richard, JP ;
Melikov, K ;
Vives, E ;
Ramos, C ;
Verbeure, B ;
Gait, MJ ;
Chernomordik, LV ;
Lebleu, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (01) :585-590
[28]   Treatment of lysosomal storage disorders - Progress with enzyme replacement therapy [J].
Rohrbach, Marianne ;
Clarke, Joe T. R. .
DRUGS, 2007, 67 (18) :2697-2716
[29]  
TANNOCK IF, 1989, CANCER RES, V49, P4373
[30]   Chances and pitfalls of cell penetrating peptides for cellular drug delivery [J].
Tréhin, R ;
Merkle, HP .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 58 (02) :209-223